Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients

scientific article published on January 1, 1978

Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.0954-6820.1978.TB14858.X
P953full work available at URLhttp://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1978.tb14858.x/fullpdf
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1978.tb14858.x
P698PubMed publication ID345754

P2093author name stringA. Melander
G. Sartor
B. Scherstén
P2860cites workPharmacokinetics of glipizide in man: Influence of renal insufficiencyQ34700096
Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous bloodQ40309783
Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabeticQ53739870
Clinical evaluation of a rapid enzyme strip method (dextrostix) for blood glucose estimationQ72613320
The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1955Q74598848
An improved glucose-oxidase method for determining blood, C.S.F. and urine glucose levelsQ78694040
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectinternal medicineQ11180
glycobiologyQ899224
P304page(s)211-214
P577publication date1978-01-01
P1433published inActa medica ScandinavicaQ10400528
P1476titleEffects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients
P478volume203

Reverse relations

cites work (P2860)
Q40307292Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs
Q34714607Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.
Q74639909Delayed hypoglycemia in a child after ingestion of a single glipizide tablet
Q51612890Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia
Q70361968Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients
Q34693555Glipizide: a review of its pharmacological properties and therapeutic use.
Q51652920Improved effect of glibenclamide on administration before breakfast.
Q39510492Influence of Food on the Bioavailability of Drugs
Q34714299Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide
Q34714382Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects
Q34708953Oral hypoglycaemic agents. An update
Q51660771Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.
Q41603300Sulfonylureas
Q51636422Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
Q72877062The effect of hyperglycaemia on the absorption of glibenclamide in patients with non-insulin-dependent diabetes mellitus
Q68531007The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels
Q39662366The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

Search more.